<DOC>
	<DOCNO>NCT01208532</DOCNO>
	<brief_summary>The aim study evaluate reliability validity Korean version European Organization Research Treatment Cancer High-dose Chemotherapy module ( EORTC HDC-29 ) .</brief_summary>
	<brief_title>Validation Study Korean Version EORTC QLQ-HDC29</brief_title>
	<detailed_description />
	<criteria>Patients age 18 year Patients diagnose hematologic malignancy plan receive highdose chemotherapy follow allogeneic autologous stem cell transplantation ( SCT ) Patients agree inform consent Patients unable complete questionnaire due serious physical psychological morbidity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>